To elucidate the clinical relevance of TAGLN2 in gastric cancer (GC), tissue microarrays comprising 75 tumor tissues and their paired normal counterparts from patients with comprehensive clinical data underwent immunohistochemistry (IHC) analysis. The gene discussed is TAGLN2; the disease is gastric cancer.